News
01-10-2025, 06:25 AM
TrialTranslator uses machine learning to assess cancer RCT generalizability, revealing survival gaps for high-risk patients and enhancing research accuracy.
More... (https://www.news-medical.net/news/20250110/Machine-learning-reveals-why-cancer-trials-fall-short-in-real-world-patients.aspx)
More... (https://www.news-medical.net/news/20250110/Machine-learning-reveals-why-cancer-trials-fall-short-in-real-world-patients.aspx)